Cyclo Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:CYTH   9:47:32 AM EDT
4.69
-0.08 (-1.68%)
Products

Cyclo Therapeutics Submits Investigational New Drug Application To U.S. FDA

Published: 11/16/2021 13:30 GMT
Cyclo Therapeutics Inc - Ordinary Shares - Class A (CYTH) - Cyclo Therapeutics Submits Investigational New Drug Application to U.S. FDA to Advance Trappsol® Cyclo™ in Phase 2 Study for Treatment of Alzheimer’s Disease.